Playing the percentages on face masks: 5 points to ponder

Around the world during the COVID-19 pandemic, words have occasionally led to blows over people in public not wearing face masks. Then too, fisticuffs have erupted over people in public wearing face masks.

Part of the problem may lie with the inherent inconstancy of the variables—mask styles, materials, fit, placement and so on.

And that’s to say nothing of the politicization of the commentary circulating online.

This further confounds evidence-based decision-making, especially outside of healthcare settings.  

Science journalist Lynne Peeples breaks it all down, citing anecdotal observations as well as scientific studies, in a 3,000-word news analysis published Oct. 6 in Nature.

Here’s the gist of five enlightening percentage-based points on which Peeples expounds.

1. A heavyweight cotton T-shirt, presumably pulled far enough up over the face, could block 50% of inhaled aerosols and almost 80% of exhaled aerosols measuring 2 micrometers across.  

2. Surgical and cloth masks of similar design may be under 70% effective at protecting the wearer.

3. In the U.S., mask-wearing in public spaces hit 50% in late July and has stayed there since.

4. That’s a significant jump from the 20% reported in March and April.

5. If the U.S. were to increase mask use to Singapore-like levels—95%—some 100,000 lives might be saved by this coming New Year’s Day.

“To be clear, the science supports using masks, with recent studies suggesting that they could save lives in different ways: Research shows that they cut down the chances of both transmitting and catching the coronavirus, and some studies hint that masks might reduce the severity of infection if people do contract the disease,” Peeples writes. “But being more definitive about how well they work or when to use them gets complicated.”

Read the whole thing.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue. 

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.